Heart Rhythm

Papers
(The median citation count of Heart Rhythm is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management521
COVID-19 and cardiac arrhythmias301
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors200
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin191
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes145
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families143
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electroc142
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review127
Left bundle branch–optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group107
Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry103
Physiology-based electrocardiographic criteria for left bundle branch capture103
The possible association between COVID-19 and postural tachycardia syndrome98
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials91
Cardiac radioablation—A systematic review86
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial86
Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia85
Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients81
Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience73
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms73
Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: The CLOSE to CURE study72
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy72
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection71
Left bundle branch pacing compared to left ventricular septal myocardial pacing increases interventricular dyssynchrony but accelerates left ventricular lateral wall depolarization68
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Gen68
Wearables in cardiology: Here to stay66
Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans64
Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study61
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure60
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation59
A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation57
Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion56
Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations55
Fixation beats: A novel marker for reaching the left bundle branch area during deep septal lead implantation53
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice53
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system52
High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants51
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study50
Postural orthostatic tachycardia syndrome as a sequela of COVID-1949
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients49
Effects of hydroxychloroquine treatment on QT interval49
Deep learning for comprehensive ECG annotation48
Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin47
Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation46
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group46
Catheter ablation of atrial fibrillation using ablation index–guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II)45
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator43
Esophageal temperature dynamics during high-power short-duration posterior wall ablation43
Electrophysiological characteristics of septal perforation during left bundle branch pacing42
His-bundle and left bundle pacing with optimized atrioventricular delay achieve superior electrical synchrony over endocardial and epicardial pacing in left bundle branch block patients42
High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.140
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up40
Ablation strategies for intramural ventricular arrhythmias37
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective37
Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis36
Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis35
Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study35
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The A34
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 201934
Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker34
Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch34
Ventricular arrhythmia risk prediction in repaired Tetralogy of Fallot using personalized computational cardiac models34
Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study34
Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction33
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate33
Leadless left ventricular stimulation with WiSE-CRT System – Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase)32
Combined local impedance and contact force for radiofrequency ablation assessment32
Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study32
Simple electrocardiographic criteria for rapid identification of wide QRS complex tachycardia: The new limb lead algorithm32
High-power, short-duration atrial fibrillation ablations using contact force sensing catheters: Outcomes and predictors of success including posterior wall isolation32
Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia32
Behavior of the PR interval with increasing heart rate in patients with COVID-1931
Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation31
Both selective and nonselective His bundle, but not myocardial, pacing preserve ventricular electrical synchrony assessed by ultra-high-frequency ECG31
Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death31
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy31
Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia30
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 201930
A novel 9-partition method using fluoroscopic images for guiding left bundle branch pacing30
Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis30
Outcomes of catheter ablation of ventricular arrhythmia originating from the left ventricular summit: A multicenter study30
Sudden cardiac death risk prediction in heart failure with preserved ejection fraction30
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria29
Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation29
Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study29
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience28
Anatomic approach with bipolar ablation between the left pulmonic cusp and left ventricular outflow tract for left ventricular summit arrhythmias28
Predictors of adverse outcome in patients with frequent premature ventricular complexes: The ABC-VT risk score28
Contrast-enhanced image-guided lead deployment for left bundle branch pacing28
High-resolution, live, directional mapping27
Axillary vein puncture guided by ultrasound vs cephalic vein dissection in pacemaker and defibrillator implant: A multicenter randomized clinical trial27
Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchrony27
Structure and function of the ventricular tachycardia isthmus27
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 527
Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled b27
Cardiac arrhythmias and sudden unexpected death in epilepsy: Results of long-term monitoring26
Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation26
Age at diagnosis of Brugada syndrome: Influence on clinical characteristics and risk of arrhythmia26
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome26
Ostial dimensional changes after pulmonary vein isolation: Pulsed field ablation vs radiofrequency ablation26
Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?25
Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)/International Society for Adult Congenit25
Temperature- and flow-controlled ablation/very-high-power short-duration ablation vs conventional power-controlled ablation: Comparison of focal and linear lesion characteristics25
Letter to the Editor—Lifesaving therapy inhibition by phones containing magnets25
Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap25
Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia24
Evaluation of the reentry vulnerability index to predict ventricular tachycardia circuits using high-density contact mapping24
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval24
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia24
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study24
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-1924
Physical activity and atrial fibrillation: Data from wearable fitness trackers23
The role of long noncoding RNAs in atrial fibrillation23
Atrioventricular junction ablation in patients with conduction system pacing leads: A comparison of His-bundle vs left bundle branch area pacing leads23
Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study23
Repeated exposure to transient obstructive sleep apnea–related conditions causes an atrial fibrillation substrate in a chronic rat model23
Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator23
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation23
Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling23
Risk stratification in patients with frequent premature ventricular complexes in the absence of known heart disease22
Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention22
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices22
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with 22
Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand22
Caring for the pregnant woman with an inherited arrhythmia syndrome22
Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point21
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy21
Cybersecurity: The need for data and patient safety with cardiac implantable electronic devices21
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk21
Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death21
Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials—Precise patient selection and measurable benefit21
Safety of leadless pacemaker implantation in the very elderly21
Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children21
Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period21
Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease21
Focal source and trigger mapping in atrial fibrillation: Randomized controlled trial evaluating a novel adjunctive ablation strategy21
Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data21
Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice21
The role of timing in treatment of atrial fibrillation: An AFFIRM substudy20
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic20
Mechanism and magnitude of bipolar electrogram directional sensitivity: Characterizing underlying determinants of bipolar amplitude20
Outer loop and isthmus in ventricular tachycardia circuits: Characteristics and implications20
The various manifestations of concealed nodofascicular/nodoventricular bypass tracts20
Improving long QT syndrome diagnosis by a polynomial-based T-wave morphology characterization20
Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study20
Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization19
Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue: Analysis using an organo-culture system19
Effect of acute and chronic ethanol on atrial fibrillation vulnerability in rats19
Pectoral nerve blocks decrease postoperative pain and opioid use after pacemaker or implantable cardioverter–defibrillator placement in children19
Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review19
Relationship of paced left bundle branch pacing morphology with anatomic location and physiological outcomes19
Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease19
Initially unexplained cardiac arrest in children and adolescents: A national experience from the Canadian Pediatric Heart Rhythm Network19
Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q, 19
Multisite conduction block in the epicardial substrate of Brugada syndrome19
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysis19
Comparison of measures of ventricular delay on cardiac resynchronization therapy response19
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment18
Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure18
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis18
Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis18
High-density epicardial mapping in Brugada syndrome: Depolarization and repolarization abnormalities18
Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion18
Nationwide burden of sudden cardiac death: A study of 54,028 deaths in Denmark18
Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management18
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence17
Blood-based 8-hydroxy-2′-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation17
Altered heart rate variability in angiotensin II–mediated hypertension is associated with impaired autonomic nervous system signaling and intrinsic sinoatrial node dysfunction17
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?17
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial17
Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedure17
Chronic venous obstruction during cardiac device revision: Incidence, predictors, and efficacy of percutaneous techniques to overcome the stenosis17
Ten-year outcomes of transcaval cardiac puncture for catheter ablation after extracardiac Fontan surgery17
Critical repolarization gradients determine the induction of reentry-based torsades de pointes arrhythmia in models of long QT syndrome17
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial17
Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial17
Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study16
Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis16
B-PO03-131 EFFECTS OF CONTACT FORCE ON LESION SIZE DURING PULSED FIELD ABLATION16
Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs16
Safety and efficacy of leadless pacemaker for cardioinhibitory vasovagal syncope16
Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart16
Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis16
Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke16
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary16
Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest16
Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins16
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation16
Individualized ablation strategy to treat persistent atrial fibrillation: Core-to-boundary approach guided by charge-density mapping16
Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar15
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome15
Optimizing lead placement for pacing in dyssynchronous heart failure: The patient in the lead15
Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation15
Programming implantable cardioverter–defibrillator in primary prevention: Guideline concordance and outcomes15
Modern mapping and ablation techniques to treat ventricular arrhythmias from the left ventricular summit and interventricular septum15
Current of injury is an indicator of lead depth and performance during left bundle branch pacing lead implantation15
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker15
Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program15
Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices15
Skin sympathetic nerve activity and ventricular rate control during atrial fibrillation15
Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients15
Static magnetic field measurements of smart phones and watches and applicability to triggering magnet modes in implantable pacemakers and implantable cardioverter-defibrillators15
Left atrial appendage occlusion using intracardiac echocardiography15
Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy15
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac15
Long-term survival following transvenous lead extraction: Importance of indication and comorbidities15
Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation15
Pursue physiological pacing therapy: A better understanding of left bundle branch pacing and left ventricular septal myocardial pacing15
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial15
Reconsidering the multiple wavelet hypothesis of atrial fibrillation15
Effect of pacemaker implantation after transcatheter aortic valve replacement on long- and mid-term mortality14
Predicting atrial fibrillation using a combination of genetic risk score and clinical risk factors14
Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures14
Predictors of loss of capture in left bundle branch pacing: A multicenter experience14
Trends in utilization and spending on remote monitoring of pacemakers and implantable cardioverter–defibrillators among Medicare beneficiaries14
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry14
Macroreentrant biatrial tachycardia relevant to interatrial septal incisions after mitral valve surgery: Electrophysiological characteristics and ablation strategy14
Electrophysiological characteristics and possible mechanism of bipolar pacing in left bundle branch pacing14
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup14
Frailty in patients undergoing percutaneous left atrial appendage closure14
Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy14
Use of virtual visits for the care of the arrhythmia patient14
Cardiac resynchronization therapy and ventricular tachyarrhythmia burden14
Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion14
Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization14
Segmental nonocclusive cryoballoon ablation of pulmonary veins and extrapulmonary vein structures: Best practices III14
Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE14
Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study14
Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter regis14
Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study13
Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome13
Implant, performance, and retrieval of an atrial leadless pacemaker in sheep13
Prospective evaluation of entrainment mapping as an adjunct to new-generation high-density activation mapping systems of left atrial tachycardias13
The many faces of early repolarization syndrome: A single-center case series13
Association between nocturnal heart rate variability and incident cardiovascular disease events: The HypnoLaus population-based study13
Impact of the type of electroanatomic mapping system on the incidence of cerebral embolism after radiofrequency catheter ablation of left atrial tachycardias13
Simultaneous epicardial–endocardial mapping of the sinus node in humans with structural heart disease: Impact of overdrive suppression on sinoatrial exits13
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises13
Effects of pulsed field ablation on autonomic nervous system in paroxysmal atrial fibrillation: A pilot study13
Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review13
Incidence of sleep apnea and association with atrial fibrillation in an unselected pacemaker population: Results of the observational RESPIRE study13
Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia13
Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm13
Intentional nontherapy in long QT syndrome13
Prior myocarditis and ventricular arrhythmias: The importance of scar pattern12
Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration12
Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review12
Feasibility of leadless left ventricular septal pacing with the WiSE-CRT system to target the left bundle branch area: A porcine model and multicenter patient experience12
Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience12
Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT12
Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study12
0.043529033660889